Department of Medicine faculty have received notice of the following research, clinical trials, CME or other training awards.
[tabs style="vertical"][tab title="Sponsored research"]Geoffrey S. Ginsburg of Cardiology has received an award (1U01-HG007282-01) from the National Institutes of Health for a project entitled "Implementation, Adoption, and Utility of Family History in Diverse Care Settings." Total funding will be $3,633,260.
Raymond J. Kim of Cardiology has received a sub-award (LSDF 3983577) through the University of Washington for a project entitled "Gd-Nanoparticles for a Safer and More Effective MRI." Total funding will be $19,939.
Rajendra H. Mehta of Cardiology has received an award from Saint John's Health Center for a project entitled "Mehta Fellows Education." Total funding will be $50,000.
Geoffrey Pitt of Cardiology has received a sub-award (1 R01-HL 113136-01) through Columbia University for a project entitled "Investigation of calcium channel modulation in cardiomyocytes by novel methods." Total funding will be $223,602.
Geoffrey Pitt of Cardiology has received an award (1R01-HL112918-01A1) from the National Institutes of Health for a project entitled "Structural studies of NaV1.5 and functional implications." Total funding will be $375,379.
Gillian D. Schmidler of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Prioritizing Research Topics." Total funding will be $266,521.
Sudha Shenoy of Cardiology has received an award from the American Heart Association for a project entitled "Regulation of vascular inflammation by the deubiquitinase USP20." Total funding will be $154,000.
Qian Wei (Mentor: Geoffrey Pitt) of Cardiology has received an award from the American Heart Association for a project entitled "Regulation of cardiac excitation-contraction coupling by fibroblast growth factor homologous factors." Total funding will be $50,000.
Matthew D. Hirschey of Endocrinology, Metabolism, and Nutrition has received a sub-award through the Ellison Medical Foundation for a project entitled "SIRT5 Regulates Mitochondrial Metabolism in Aging and Disease." Total funding will be $100,000.
Ranee Chatterjee Montgomery of General Internal Medicine has received a sub-award (U01-DK098245-01) through Tufts University for a project entitled "Vitamin D to prevent type 2 diabetes (D2d study)." Total funding will be $89,543.
Harvey Jay Cohen of Geriatrics has received an award from the John A. Hartford Foundation, Inc. for a project entitled "John A. Hartford Foundation's Centers of Excellence (CoE)." Total funding will be $73,000.
John A. Bartlett of Infectious Diseases has received a sub-award (CT2900-WCHS) through Wake County Human Services for a project entitled "HIV Adult ID Services through Wake County, Year 4." Total funding will be $148,297.
John A. Bartlett of Infectious Diseases has received a sub-award (7UM1-AI068636-07) through the Brigham and Women's Hospital for a project entitled "Performance Evaluation Committee-Yr 7B." Total funding will be $18,857.
Vance G. Fowler Jr. of Infectious Diseases has received an award (1UM1-AI104681-01) from the National Institutes of Health for a project entitled "ARLG-Statistics and Data Management Center."
Vance G. Fowler Jr. of Infectious Diseases has received an award (HHSN272200900023C) from the National Institutes of Health for a project entitled "Modification No. 7 - Staphylococcal Bacteremia Study." Total funding will be $458,627.
Vance G. Fowler Jr. of Infectious Diseases has received an award (1UM1-AI104681-01) from the National Institutes of Health for a project entitled "ARLG-Laboratory Center."
Vance G. Fowler Jr. of Infectious Diseases has received an award (1UM1-AI104681-01) from the National Institutes of Health for a project entitled "ARLG-Leadership and Operations Center." Total funding will be $62,000,000.
Charles B. Hicks of Infectious Diseases has received a sub-award (HHSN266200600019C) through the Argos Therapeutics, Inc. for a project entitled "A Randomized, Double Blind, Phase 2B Study Testing the Efficacy and Safety of AGS-004 on Host Control of HIV Replication during Analytical Treatment Interruption, AGS-004-003." Total funding will be $106,947.
Mehri McKellar of Infectious Diseases has received a sub-award (2B08T1010032) through the NC DHHS for a project entitled "Substance Abuse Center-5 (SAC-5): Counseling, Testing and Referral in Durham, Caswell, Orange, Person and Wake." Total funding will be $25,000.
Wendy A. Prudhomme - O'Meara of Infectious Diseases has received a sub-award (AID-623-A-12-00001) through Indiana University for a project entitled "USAID - AMPATH PLUS." Total funding will be $12,673.
Allison E. Ashley-Koch of Medical Genetics has received a sub-award (1RC4-HD067971-01) through Creighton University for a project entitled "Mechanisms Underlying Gestational Fumonisin Exposure and Neural Tube Defects." Total funding will be $1,272,879.
Victoria L. Seewaldt of Medical Oncology has received a sub-award (5U54 -CA143836-04) through the University of California - Berkeley for a project entitled "Minority Supplement." Total funding will be $158,526.
Steven D. Crowley of Nephrology has received an award from the American Heart Association for a project entitled "The Role of T Lymphocyte Transmigration in the Pathogenesis of Hypertensive Kidney Injury." Total funding will be $154,000.[/tab][tab title="Industry-sponsored clinical trials"]David F. Kong of Cardiology has received an award from Abbott Vascular Devices for a project entitled "Absorb III Randomized Controlled Trial." Total funding will be $925,770.
Robert J. Noveck of Cardiology has received an award from Perosphere, Inc. for a project entitled "PER977 PK Study." Total funding will be $1,793,391.
Wanda Lakey of Endocrinology, Metabolism, and Nutrition has received an award from Janssen Research & Development, LLC for a project entitled "Obesity, hsCRP and D-dimer in HIV-infected patients after antiretroviral therapy." Total funding will be $46,966.
Andrew J. Muir of Gastroenterology has received an award from Vertex Pharmaceuticals Inc. for a project entitled "Vertex Scientific and Educational Support Agreement." Total funding will be $40,000.
Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Gilead Education Grant." Total funding will be $5,000.
Keyur Patel of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "GS US 342 0109." Total funding will be $81,737.
Mitchell E. Horwitz of Hematological Malignancies and Cellular Therapy has received an award from the National Marrow Donor Program for a project entitled "A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies. CIBMTR 09 PLEX." Total funding will be $42,000.
Barbara D. Alexander of Infectious Diseases has received an award from Viropharma, Inc. for a project entitled "Phase 2 Randomized Study to Assess Safety and Anti-Cytomegalovirus Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant/Refractory to Treatment with Ganciclovir/Valganciclovir/Foscarnet in Transplant Recipients." Total funding will be $241,543.
Mehri McKellar of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 3, Open Label Study to Evaluate Switching from a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically Suppressed, HIV 1 Positive Subjects (GS-US-292-0109)." Total funding will be $107,425.
Jeffrey Crawford of Medical Oncology has received an award from the Mayo Clinic for a project entitled "A Randomized Phase 2 Trial of Erlotinib Alone or In Combination with Bevacizumab in Patients with Non-Small Cell Lung Cancer." Total funding will be $48,270.
April K. Salama of Medical Oncology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "A phase 1b/II, multicenter, study of CLEE011 in combination with LGX818 in adult patients with BRAF mutation melanoma." Total funding will be $227,506.
John H. Strickler of Medical Oncology has received an award from F. Hoffmann-La Roche Ltd for a project entitled "A randomized phase III multicenter double blind placebo controlled study evaluating the efficacy and safety on Onortuzumab (MetMAb) in combination with 5Fluroruracil, folinic acid and oxaliplatin (mFOLFOX6) in patients with metastatic." Total funding will be $241,736.[/tab]
[/tabs]